UBS Maintains Buy on Alkermes, Raises Price Target to $48
Alkermes Public Limited Company
Alkermes Public Limited Company ALKS | 0.00 |
UBS analyst Ashwani Verma maintains Alkermes (NASDAQ:
ALKS) with a Buy and raises the price target from $42 to $48.